Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasm, Residual × ibrutinib × 30 days × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 13 Lymphoma, Non-Hodgkin 6 Lymphoma, Mantle-Cell 5 Waldenstrom Macroglobulinemia 4 Lymphoma, Large B-Cell, Diffuse 4 Lymphoma, Follicular 3 Recurrence 2 Neoplasms 2 Lymphoma 2 Leukemia, Hairy Cell 2 Hematologic Diseases 2 Burkitt Lymphoma 2 Multiple Myeloma 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma, B-Cell 1 Leukemia, Lymphoid 1 Leukemia, B-Cell 1 Leukemia 1 Bronchiolitis Obliterans Syndrome 1 Bone Marrow Diseases 1

Interventions

pembrolizumab 2 fludarabine 2 blinatumomab 2 tislelizumab 1 tisagenlecleucel 1 tetrathiomolybdate 1 relugolix 1 nilotinib 1 isatuximab 1 inavolisib 1 giredestrant 1 fludarabine phosphate 1 enzalutamide 1 abemaciclib 1 Transplantation 1 Monatide (IMS 3015) 1 Melphalan 1 Lenalidomide 1 Immunotherapy 1 Imatinib Mesylate 1 HMPL-013 1 Docetaxel 1 Dexamethasone 1 Dasatinib 1 Cyclophosphamide 1 Capecitabine 1 Calcium Dobesilate 1 Biological Assay 1 ALT-803 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡